Top movers from today's pull-back 📉

[Image](www.elitetrade.club) Good Afternoon! Hey, everyone. It's Adam from Elite Trade Club. Welcome to the Closing Bell Roundup. Please, feel free to reply to this email and tell us what you think of this new addition to the Elite Trade Club lineup! It's Wednesday, November 9th. I hope you had a great day! Here's what moved the market today: Markets 📈 Stocks pulled back today after starting the week strong. The Nasdaq [-2.4%] was the biggest large-cap loser, followed by the S&P 500 [-2.0%] and Dow [-1.9%]. The small-cap Russell 2K [-2.6%] also underperformed. Sthttps:// with 200elitetra.de/JO7z Sponsored [The Key to the EV Revolution Isn't Lithium...]( 🚨 Did you know each electric car battery requires 220 pounds of graphite - more than lithium, copper, or aluminum? China controls more than 90% of this vital ingredient. But the U.S. just classified graphite as "essential for America's National Defense"... And one little-known company is looking to win big in the energy war with China. If it's successful, it could deliver massive gains for shareholders. [Find Out How the Energy War with China Could Skyrocket this Stock]( Today's Market-Moving News 🔎 - Binance to Buy FTX: Binance has agreed to acquire rival crypto exchange FTX, but early reports say the deal could already be in jeopardy. Bitcoin [BTC -13.6%] and other cryptos sold off on the news. Today's Top Winners and Losers 🔥 Telos Corp [TLS] $3.44 (-68.8%) Telos issued underwhelming Q4 revenue guidance of $43 million to $47 million on its Q3 earnings report, which fell short of The Street's $64.4 million estimate. Wedbush called the guidance a "train wreck" and lowered its price target to $8 from $15 on the news. Timber Pharmaceuticals Inc [TMBR] $1.53 (-48.2%) Timber Pharmaceuticals implemented a 1-for-50 stock split in today's session after announcing the measure Tuesday evening. The news sent the stock to a steep loss. Amyris Inc [AMRS ://elitetra.de/L2Ic ] $1.515 (-41.5%) Amyris fell after posting disappointing revenues and EPS on its Q3 earnings report. AMRS reported a loss of -$(0.44) per share against consensus of -$(0.21), and revenues of $71.1 million missed analysts' estimate of $91.2 million. Merrimack Pharmaceuticals Inc [MACK] $12.51 (+212.7%) Phase 3 drug data from European pharma firm Ipsen seems to indicate that its Onivyde drug is on course for an approval. If approved, Merrimack, a holding company, would be in line to receive a $225 million milestone payment. Investors believe the windfall will be distributed to shareholders, so shares are soaring on the news. OutSet Medical Inc [OM] $14.90 (+29.9%) OutSet Medical's Q3 earnings report showed a non-GAAP loss of -$(0.70) per share on revenues of $27.8 million and FY guidance of $111.0 to $113.0 million, surpassing Wall Street's expectations. Consensus estimates were EPS of -$(0.81) on revenues of $25.2 million on FY2022 guidance of $108.0 million. Riskified Ltd [RSKD] $5.11 (+24.9%) Riskified's Q3 results beat analysts' expectations. The company reported a loss of -$(0.05) per share against the Street's -$(0.14) EPS estimate. Revenues grew more than 20% to $63.17 million and beat the consensus estimate of $58.99 million by 7.0%. That's it for today! Please, write us back, and let us know what you think of the Closing Bell Roundup. We're always eager to hear feedback from our members! Thanks for reading. I'll see you at the next open! Best Regards, Adam G. -- Elite Trade Club P.S... If you're on the hunt for a new broker, check out our preferred partner, moomoo! You can [get 15 free stocks]( worth up to $2,000 each if you join the moomoo App now. [Click here to get started.]( alerts delivered straight to your cell every morning for free?* P.P.S... Text ELITE to 47121 or [click here]( to sign up now and get our watchlists sent directly to your phone! You can also text CLOSE to 47121 or [click here]( to get the Closing Bell Roundup sent to your mobile inbox, too! *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](